Lantheus Holdings, Inc. Profile Avatar - Palmy Investing

Lantheus Holdings, Inc.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound en…
Drug Manufacturers - Specialty & Generic
US, North Billerica [HQ]

Ratios

13 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
26.72 26.10 27.27 41.62 46.18 45.64 48.93 50.93 50.33 40.88 44.14 62.21 54.73
Profit Margin
-38.52 -14.58 -21.70 -1.18 -5.02 8.87 37.23 11.80 9.12 -3.97 -16.76 3.00 25.20
Operating Margin
-4.85 -0.26 -6.66 13.07 14.49 18.75 15.65 18.78 9.23 -1.24 -17.89 -1.44 28.13
EPS Growth
- - 68.99 -44.07 94.12 -200.00 240.00 294.05 -67.98 -23.59 -130.86 -324.00 138.68 1,068.29
Return on Assets (ROA)
- - -12.94 -23.56 -1.43 -6.08 10.46 32.14 9.21 7.80 -1.55 -8.25 2.12 19.78
Return on Equity (ROE)
- - 24.26 26.14 1.49 7.96 -25.12 529.75 57.07 27.63 -2.62 -15.35 6.28 40.04
Return on Invested Capital (ROIC)
- - -0.29 -11.20 35.31 31.65 31.19 55.38 15.63 11.49 -0.67 -11.31 -1.40 20.23
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
- - 131.83 155.77 163.19 145.85 108.68 69.86 60.58 47.81 25.11 20.23 42.24 37.37
Debt/Equity
- - -247.23 -172.83 -170.22 -190.79 -261.10 1,151.27 375.28 169.34 42.47 37.63 124.81 75.62
Debt/EBITDA
- - 1,349.06 2,955.63 671.67 765.13 450.06 317.16 228.61 222.60 -6,939.40 -91.39 412.89 -21.77
Debt/Capitalization
- - 167.92 237.31 242.41 210.15 162.07 92.01 78.96 62.87 29.81 27.34 55.52 43.06
Interest Debt per Share USD
- - 26.41 24.89 25.25 16.05 9.51 7.69 7.42 5.33 4.21 2.70 8.25 9.33
Debt Growth
- - - - 2.06 0.06 -13.20 -21.33 -3.58 -0.63 -27.17 12.54 -19.98 219.33 10.55
Liquidity
Current Ratio
- - 172.18 142.45 167.40 252.26 252.79 316.26 370.42 261.55 228.84 260.55 273.56 579.57
Quick Ratio
- - 134.54 103.92 126.78 184.47 200.73 249.30 297.89 206.39 165.97 207.57 253.95 532.67
Cash Ratio
- - 59.43 33.40 40.68 80.06 116.74 163.19 214.96 140.55 98.89 108.85 167.80 380.92
Operating Cash Flow Ratio
- - - - - - - - - - 100 100 100 100 - - - - 100 100
Turnover
Inventory Turnover
- - 1,179.68 1,126.77 1,130.03 1,011.00 930.12 648.94 510.28 591.25 561.35 676.12 996.08 916.59
Receivables Turnover
- - 684.08 723.01 721.76 786.91 819.85 823.12 784.80 797.94 628.51 475.97 438.18 456.02
Payables Turnover
- - 1,123.82 1,139.65 1,124.04 1,354.89 866.28 969.10 938.40 927.16 1,232.19 1,142.60 1,718.42 1,424.86
Asset Turnover
- - 88.74 108.56 120.85 121.08 117.96 86.33 78.07 85.57 39.02 49.23 70.77 78.52
Coverage
Interest Coverage
-45.89 -1.79 -44.02 93.21 109.85 212.59 281.66 370.51 235.45 -44.29 -981.53 -187.01 1,821.48
Asset Coverage
- - - - - - - - - - - - 100 100 100 100 200 100 200
Cash Flow Coverage (CFGR)
- - -0.09 -3.83 2.85 6.16 17.85 20.43 22.97 41.42 7.51 30.85 50.49 49.48
EBITDA Coverage
- - - - - - 100 100 100 300 300 300 - - -1,000 400 2,200
Dividend Coverage
100 1,100 50,000 - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
- - - - - - 100 100 100 100 100 100 - - - - 100 200
Market Prospects
Dividend Yield
82.84 2.92 0.10 - - - - - - - - - - - - - - - - - - - -
Earnings Yield
-112.44 -34.87 -50.29 -2.95 -17.85 9.71 16.19 6.77 3.96 -1.85 -3.66 0.80 7.72
Price/Earnings (P/E)
-88.94 -286.82 -198.86 -3,385.00 -560.20 1,029.74 617.82 1,476.74 2,525.16 -5,420.23 -2,735.27 12,434.88 1,295.68
Price/Book (P/B)
- - -69.59 -51.97 -50.38 -44.58 -258.72 3,272.91 842.72 697.76 142.02 419.79 780.53 518.76
Price/Sales (P/S)
34.26 41.81 43.15 39.97 28.15 91.30 230.04 174.26 230.22 215.16 458.52 373.25 326.47
Price/Cash Flow (P/CF)
525.99 -32,383.21 -786.08 1,040.03 379.59 555.13 1,391.63 977.80 994.78 4,453.94 3,616.13 1,238.59 1,386.52
End of LNTH's Analysis
CIK: 1521036 CUSIP: 516544103 ISIN: US5165441032 LEI: - UEI: -
Secondary Listings
LNTH has no secondary listings inside our databases.